| pharyngeal veins | Several veins from the pharyngeal venous plexus emptying into the internal jugular vein. Synonym: venae pharyngeae. (05 Mar 2000) |
|---|---|
| mylopharyngeal part of superior pharyngeal constrictor | See: superior constrictor muscle of pharynx. Synonym: pars mylopharyngeus musculi constrictoris pharyngis superioris. (05 Mar 2000) |
| cricopharyngeal part of inferior pharyngeal constrictor | See: inferior constrictor muscle of pharynx. Synonym: pars cricopharyngea musculi constrictoris pharyngis inferioris. (05 Mar 2000) |
| sphincter of the pharyngeal isthmus | A constant band of the superior pharyngeal constrictor muscle which sweeps posteriorly from the anterolateral part of the superior surface of the palatine aponeurosis. It creates a visible ridge when the superior constrictor is contracted, meeting the elevated soft palate to seal off the pharyngeal isthmus during swallowing. Synonym: pharyngeal ridge, sphincter of the pharyngeal isthmus, velopharyngeal sphincter. (05 Mar 2000) |
| syndrome, third and fourth pharyngeal pouch | See syndrome, digeorge. (12 Dec 1998) |
| third and fourth pharyngeal pouch syndrome | <syndrome> Also called the digeorge syndrome (dgs), this disorder is characterised by (1) low blood calcium levels (hypocalcaemia) due to underdevelopment (hypoplasia) of the parathyroid glands which control calcium; (2) underdevelopment (hypoplasia) of the thymus, an organ behind the breastbone in which lymphocytes mature and multiply; and (3) defects of the heart involving the outflow tracts more than from the heart. most cases of dgs are due to a microdeletion in chromosome band 22q11.2. A small number of cases have defects in other chromosomes, notably 10p13. Named after the american paediatric endocrinologist angelo digeorge. Another name for dgs is hypoplasia of the thymus and parathyroids. (12 Dec 1998) |
| thyropharyngeal part of inferior pharyngeal constrictor muscle | thyropharyngeal part of inferior pharyngeal constrictor muscle |
| lateral pharyngeal space | That part of the peripharyngeum spatium located at the sides of the pharynx. Synonym: spatium lateropharyngeum. (05 Mar 2000) |
| bladder neoplasms | Cancers or tumours of the bladder. The majority of bladder neoplasms are of the transitional cell variety and are usually papillary and multicentric. (12 Dec 1998) |
| bone marrow neoplasms | Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as myeloma. most bone marrow neoplasms are metastatic. (12 Dec 1998) |
| breast neoplasms, male | Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females. Two-thirds of patients present with intraductal carcinoma. The average age of onset is 60 years for men. Orchiectomy was the standard treatment but it has been replaced by tamoxifen as the initial therapy since oestrogen-receptor-positive tumours are predominant in males. Orchiectomy and mastectomy may be used if initial drug therapy is not successful. The prognosis is worse than that for females. (12 Dec 1998) |
| vascular neoplasms | <oncology> Neoplasms located in vascular tissue or specific veins. They are differentiated from neoplasms, vascular tissue which are neoplasms composed of vascular tissue, such as angiofibroma or haemangioma. (12 Dec 1998) |
| pancreatic cystic neoplasms | <radiology> Microcystic adenoma, glycogen, benign, mucinous cystic neoplasm, macrocystic adenoma, cystadenoma/cystadenocarcinoma, mucin, pre-malignant, Both occur more commonly in women, peak in middle age (12 Dec 1998) |
| pancreatic neoplasms | <radiology> Adenocarcinoma, most common, usually in pancreatic head, nasty (1-2% survival at 1 yr!), cystic neoplasms, slow-growing, more common in women, isleT-cell tumours, soft-tissue tumours (rare), metastases (breast, lung, melanoma, stomach, colon) (12 Dec 1998) |
| mammary neoplasms | Tumours of the mammary gland. Their occurrence is uncommon with the exception of the female dog, in which they account for 25% of all neoplasms. (12 Dec 1998) |